Name
Purdue University Globle
NU506 Health Policy, Ethical, and Legal Perspectives of the Health Care System
Prof. Name
Date
Perinatal mood disorders are common mental health conditions that can develop during pregnancy or after childbirth, and early screening, clinical assessment, treatment, and follow-up are essential for protecting the health of mothers, infants, and families. Postpartum depression (PPD) affects a substantial proportion of postpartum individuals, yet it is frequently underrecognized because symptoms may be mistaken for normal postpartum adjustment or may not be disclosed because of stigma. The Waldo County Hospital Perinatal Mood Disorders Policy addresses these concerns by establishing standardized screening procedures, defining provider responsibilities, and connecting patients with treatment and community resources throughout the MaineHealth system.
Postpartum depression can affect approximately 10%–20% of postpartum individuals, although estimates vary depending on the population studied and the diagnostic or screening criteria used. Standardized screening gives healthcare professionals more opportunities to identify depression and anxiety symptoms early and initiate appropriate evaluation and treatment. A coordinated approach is especially important because untreated perinatal depression can affect maternal functioning, mother–infant relationships, family wellbeing, and, in severe cases, maternal safety.
The Waldo County Hospital policy demonstrates how an institutional healthcare policy can incorporate evidence-based screening tools, clinical decision-making, electronic health record workflows, patient education, and community resources into routine maternal and newborn care.
Perinatal mood disorders describe a group of mental health conditions that can occur during pregnancy or after childbirth. These conditions include depression, anxiety disorders, obsessive-compulsive symptoms, bipolar disorders, and postpartum psychosis. Although these disorders differ in their symptoms and treatment, they can all affect maternal wellbeing and the ability to safely care for an infant.
Postpartum depression is one of the most clinically significant perinatal mental health conditions. It involves persistent depressive symptoms that interfere with daily functioning and may occur shortly after childbirth or later during the postpartum period. Importantly, depression associated with pregnancy does not necessarily begin after delivery. Symptoms may begin during pregnancy and continue into the postpartum period.
Common symptoms can include:
Persistent sadness, emptiness, or hopelessness
Loss of interest or pleasure in activities
Excessive anxiety or persistent worry
Feelings of guilt, shame, or inadequacy
Difficulty bonding with the infant
Significant changes in sleep or appetite
Fatigue or decreased energy
Difficulty concentrating or making decisions
Feelings of worthlessness
Thoughts of death, self-harm, or harming the infant
Some fatigue, sleep disruption, and emotional changes are expected during the transition to parenthood. However, symptoms that are persistent, severe, worsening, or interfering with daily functioning warrant further clinical evaluation.
Postpartum depression is both a maternal health concern and a family health concern. A mother’s emotional and psychological wellbeing can influence infant care, parent–infant bonding, family relationships, and the child’s social and emotional environment.
Research has associated persistent maternal depression with adverse behavioral and executive-function outcomes in children. Untreated severe depression can also create significant safety concerns, including suicidal thoughts or behavior. Postpartum psychosis, although rare, is a psychiatric emergency that requires immediate evaluation and intervention.
Routine screening can help healthcare professionals identify symptoms that may otherwise remain hidden. Screening is particularly valuable because some patients may not voluntarily report depression due to shame, fear of judgment, cultural expectations, or concerns that disclosure could affect their ability to parent.
Family Nurse Practitioners (FNPs) and other advanced practice registered nurses (APRNs) have important opportunities to recognize perinatal mental health concerns because they may encounter patients during primary care, reproductive health, postpartum, and family-centered visits.
Healthcare organizations use clinical policies to establish consistent practices, clarify professional responsibilities, and support evidence-based care. Without standardized procedures, postpartum depression screening may occur inconsistently or only after symptoms become severe.
The Waldo County Hospital Perinatal Mood Disorders Policy was developed to improve recognition and management of perinatal mood disorders within the MaineHealth system. The policy establishes a structured process for screening, assessment, education, referral, and follow-up.
The policy emphasizes several important objectives:
Identifying patients who may be at increased risk for perinatal mood disorders
Using validated depression screening instruments
Establishing follow-up procedures after positive screening results
Connecting patients with mental health and community resources
Improving communication among nurses, physicians, advanced practice providers, pediatric clinicians, and other members of the healthcare team
A standardized approach helps reduce variations in practice and creates a more reliable pathway from screening to treatment.
Postpartum depression should be considered a healthcare quality and patient safety issue because delayed recognition can prevent patients from receiving appropriate treatment. Healthcare policies that standardize screening can improve consistency while supporting earlier clinical intervention.
The World Health Organization describes health policy as decisions, plans, and actions undertaken to achieve specific healthcare goals. Effective clinical policies establish expectations for care and help organizations coordinate resources toward measurable health outcomes.
The Waldo County Hospital policy applies these principles to perinatal mental health by establishing a framework that integrates screening into maternal and newborn care. Rather than relying exclusively on individual clinicians to recognize symptoms, the policy creates a systematic process for identifying and responding to potential mental health concerns.
Advanced practice registered nurses, including Family Nurse Practitioners, play an important role in identifying depression and other mental health conditions during the perinatal period. Their broad scope of practice and continued patient relationships create opportunities for early recognition.
Postpartum depression symptoms can overlap with ordinary experiences associated with childbirth, including fatigue, sleep disruption, changes in appetite, and emotional stress. Consequently, APRNs must combine screening results with clinical judgment and a comprehensive patient assessment.
An effective nursing approach includes recognizing warning signs, using validated screening instruments, assessing safety, educating patients, coordinating referrals, and supporting continuity of care.
A therapeutic relationship is particularly important because patients may be hesitant to discuss emotional difficulties. Compassionate, nonjudgmental communication can make it easier for patients to disclose symptoms and accept recommendations for treatment.
One challenge in addressing postpartum depression is that professional organizations and clinical resources may describe the condition using somewhat different terminology and timeframes. The term postpartum depression is commonly used in clinical practice, while the DSM-5-TR uses the concept of a depressive disorder with a peripartum onset specifier.
The DSM-5-TR recognizes depressive episodes that begin during pregnancy or within the postpartum period. This distinction is clinically important because depression can begin before delivery rather than appearing exclusively after childbirth.
The broader concept of perinatal depression therefore recognizes that mental health assessment should begin during pregnancy and continue after delivery.
Differences in terminology should not prevent clinicians from screening patients. Instead, healthcare organizations can use standardized policies and validated screening tools to create consistent opportunities for identification and referral.
Professional organizations generally support screening for perinatal depression, but recommendations can differ regarding timing, setting, workflow, and follow-up procedures.
The American College of Obstetricians and Gynecologists (ACOG) recommends screening patients for depression and anxiety using standardized, validated instruments at the initial prenatal visit, later in pregnancy, and during postpartum visits. ACOG also emphasizes that screening should occur within a system that supports assessment, diagnosis, treatment, and appropriate follow-up.
The American Academy of Pediatrics (AAP) recommends that pediatric healthcare professionals screen mothers for postpartum depression during infant healthcare visits. Pediatric appointments can provide additional opportunities to identify maternal depression because mothers frequently interact with pediatric providers during the infant’s first year.
Integrating maternal mental health screening into both obstetric and pediatric care creates multiple opportunities for identification. This approach is particularly useful because some patients may develop symptoms after their routine postpartum obstetric visits.
When screening is inconsistent, patients experiencing depression may not be identified until symptoms become more severe. Several barriers can contribute to underdiagnosis, including stigma, inadequate screening protocols, limited provider training, uncertainty about what constitutes a normal postpartum adjustment, and limited access to mental health services.
Patients may also minimize their symptoms because they fear being judged as an inadequate parent. Cultural expectations and concerns about social services can further discourage disclosure.
Standardized screening does not eliminate these barriers, but it creates a reliable mechanism for initiating conversations about mental health and identifying patients who need additional assessment.
The Waldo County Hospital Perinatal Mood Disorders Policy was developed to strengthen the identification and management of perinatal mood disorders within the MaineHealth healthcare system. The policy provides healthcare professionals with a structured approach for screening patients, responding to concerning results, providing education, and connecting families with available resources.
The policy’s central goals include identifying individuals at increased risk, standardizing depression screening, establishing follow-up procedures, improving interdisciplinary communication, and connecting patients with treatment and community services.
The policy involves multiple professionals participating in maternal and newborn care, including:
Labor and delivery nurses
Obstetric providers
Advanced practice nurses
Primary care providers
Pediatric providers
Mental health professionals
Social service professionals
This interdisciplinary model recognizes that postpartum depression cannot be effectively addressed by one profession alone.
Nurses are central to the implementation of postpartum depression screening because they frequently have extended contact with patients during labor, delivery, postpartum hospitalization, and discharge planning.
Within a standardized hospital policy, nurses may be responsible for completing approved depression screening assessments, reviewing responses, identifying risk factors, providing patient education, documenting findings, and communicating concerns to the appropriate healthcare provider.
Before discharge, postpartum nursing care should include more than completing a questionnaire. Screening results should be incorporated into the patient’s overall assessment and discharge plan.
When concerns are identified, appropriate follow-up may involve:
Additional clinical assessment
Provider notification
Mental health consultation
Safety assessment
Referral to community resources
Patient and family education
Follow-up appointment planning
This approach makes postpartum depression screening part of a comprehensive care pathway rather than an isolated administrative task.
Validated screening instruments can help healthcare professionals identify patients who may require additional evaluation. Two commonly used tools are the Edinburgh Postnatal Depression Scale (EPDS) and the Patient Health Questionnaire-9 (PHQ-9).
These instruments are screening tools rather than standalone diagnostic tests. An elevated score should prompt clinical assessment rather than automatically establishing a diagnosis.
The Edinburgh Postnatal Depression Scale is a 10-item questionnaire widely used to screen for depression and anxiety symptoms during pregnancy and after childbirth.
The EPDS focuses primarily on psychological symptoms rather than physical symptoms that may overlap with normal pregnancy or postpartum experiences. Patients respond based on symptoms experienced during the preceding seven days.
The EPDS can help clinicians identify patients who may benefit from further assessment. It can also facilitate conversations about mood, anxiety, coping, and safety.
An important limitation is that an EPDS score alone does not establish a diagnosis. Healthcare providers must interpret the result within the patient’s clinical circumstances and complete additional assessment when indicated.
The Patient Health Questionnaire-9 is a nine-item depression screening instrument based on diagnostic criteria for depressive disorders. It assesses symptoms such as depressed mood, loss of interest, sleep changes, fatigue, appetite changes, concentration difficulties, psychomotor changes, feelings of worthlessness, and thoughts of death or self-harm.
The PHQ-9 can be used to estimate the severity of depressive symptoms and monitor changes over time. Its relatively short format makes it practical for primary care, obstetric, and other clinical settings.
Like the EPDS, the PHQ-9 should be used as part of a broader clinical assessment rather than as a substitute for diagnostic evaluation.
A positive depression screening result requires appropriate follow-up. Patients who report suicidal thoughts, thoughts of harming others, psychotic symptoms, or other serious safety concerns require immediate clinical evaluation.
Safety procedures may include ensuring that the patient is not left alone when there is an immediate safety risk, notifying the responsible healthcare professional, obtaining an urgent mental health evaluation, involving appropriate support services, and establishing a safe disposition.
Postpartum psychosis is particularly important to recognize because it is rare but potentially life-threatening. Symptoms such as hallucinations, delusions, severe confusion, extreme agitation, or markedly disorganized behavior require emergency psychiatric assessment.
The key principle is that screening identifies potential risk; clinical assessment determines the appropriate response.
The Waldo County Hospital policy extends beyond nursing responsibilities. All healthcare professionals involved in prenatal, postpartum, and newborn care have an important role in recognizing and responding to perinatal mental health concerns.
Providers should incorporate screening into routine clinical encounters rather than waiting for a patient to report severe symptoms. Screening should be followed by appropriate assessment, diagnosis when indicated, treatment planning, and ongoing monitoring.
A coordinated screening schedule can create multiple opportunities to identify symptoms during pregnancy and after delivery. The exact timing and workflow should follow the organization’s current policy and applicable professional guidelines.
Pediatric visits provide an important opportunity to identify postpartum depression. Mothers frequently attend multiple infant wellness appointments during the first year, even when they do not return consistently for their own postpartum care.
Pediatric clinicians can therefore ask about maternal emotional wellbeing, use validated screening instruments when appropriate, and connect families with medical or mental health services.
Including maternal depression screening within pediatric care reflects the relationship between maternal wellbeing and infant health. When depression affects a parent, the infant and broader family system may also be affected.
A positive EPDS or PHQ-9 result should initiate additional clinical evaluation rather than automatically lead to a diagnosis of postpartum depression.
The assessment should consider symptom severity, duration, functional impairment, previous psychiatric history, social support, substance use when relevant, current treatment, and patient preferences.
Safety assessment is particularly important. Clinicians should determine whether the patient has suicidal thoughts, thoughts of harming the infant or another person, psychotic symptoms, or other urgent concerns.
A history of bipolar disorder should also be considered before initiating antidepressant treatment. Screening for bipolar disorder can help reduce the risk of inappropriate treatment of an underlying bipolar condition.
Treatment decisions should be individualized and may involve psychotherapy, medication, peer or community support, or a combination of interventions. Patients with severe symptoms or immediate safety concerns may require urgent psychiatric care.
Electronic health records can strengthen standardized screening programs by incorporating validated questionnaires directly into clinical workflows. The MaineHealth implementation described in the policy used the EPIC electronic health record system to support screening and documentation.
EHR integration can make it easier for healthcare professionals to document screening completion, calculate scores, identify concerning results, communicate findings, and monitor follow-up.
Potential advantages include improved documentation consistency, faster recognition of concerning results, better interdisciplinary communication, and easier monitoring of screening performance.
Electronic systems should support rather than replace clinical judgment. A patient may have significant concerns even when a screening score does not indicate a high level of risk, and clinicians should investigate symptoms that raise clinical concern.
Postpartum depression screening is most effective when patients understand why screening is being performed and know where to obtain help. Patient education can reduce stigma and normalize conversations about emotional wellbeing after childbirth.
Education should explain that perinatal depression is a treatable health condition rather than a sign of personal failure. Patients should also receive information about symptoms, treatment options, community resources, and emergency services when appropriate.
The Waldo County Hospital policy incorporates community support resources into its approach to perinatal mental healthcare.
CradleME is a Maine-based referral resource that helps connect families with home-based support programs. These services can provide practical assistance, parenting support, education, and connections to public health resources.
Community-based services can be particularly important for families experiencing social isolation, limited support, financial stress, transportation challenges, or difficulty adjusting to parenthood.
Connecting patients with community resources extends care beyond the hospital and may help families access ongoing support after discharge.
Healthcare organizations must consider the costs associated with implementing clinical policies. Postpartum depression screening programs may require staff education, workflow changes, electronic health record development, administrative planning, and coordination with community resources.
However, early identification may provide long-term value by helping patients receive treatment before symptoms become more severe. Effective intervention can potentially reduce the need for emergency psychiatric care, hospitalization, and other costly healthcare services associated with untreated severe depression.
The financial impact of implementation depends on the organization’s existing infrastructure, staffing model, patient population, and availability of community services. Therefore, organizations should evaluate both implementation costs and measurable outcomes when assessing a screening program.
Postpartum depression screening can be viewed as a secondary prevention strategy because it focuses on identifying a health problem early and reducing its potential consequences.
The purpose of screening is not simply to increase the number of assessments completed. The ultimate goal is to ensure that patients who need help are identified and connected with appropriate care.
Early identification can support:
Timely clinical assessment
Reduction of untreated symptoms
Improved maternal functioning
Safer care for patients experiencing severe symptoms
Healthier parent–infant relationships
Improved family wellbeing
Earlier access to mental health treatment
Screening cannot prevent every case of postpartum depression, but it can reduce delays between symptom development, recognition, and treatment.
A major strength of the Waldo County Hospital Perinatal Mood Disorders Policy is its emphasis on standardization. By establishing expectations for screening, documentation, referral, education, and follow-up, the policy reduces reliance on individual provider practices.
Other strengths include the use of validated screening instruments, interdisciplinary collaboration, EHR integration, patient education, and connections to community resources.
The policy also recognizes that perinatal mental healthcare extends across different healthcare settings. Collaboration among obstetric, nursing, primary care, pediatric, and mental health professionals creates additional opportunities to identify patients who might otherwise be missed.
Although standardized screening policies can improve identification, screening alone does not guarantee treatment or recovery. Patients may decline screening, minimize symptoms, or feel uncomfortable discussing mental health concerns.
Healthcare systems may also face barriers such as limited mental health provider availability, inadequate reimbursement, transportation challenges, rural healthcare access issues, and delays in obtaining specialized services.
Another challenge is ensuring that staff remain knowledgeable about screening tools, referral pathways, safety procedures, and current clinical recommendations.
Successful implementation therefore requires more than a written policy. Organizations need ongoing staff education, reliable workflows, appropriate referral resources, leadership support, and mechanisms for monitoring outcomes.
The Waldo County Hospital Perinatal Mood Disorders Policy provides a structured approach to improving the recognition and management of postpartum depression and other perinatal mental health conditions. Postpartum depression is common, clinically significant, and treatable, but many affected individuals remain unidentified because of inconsistent screening, stigma, limited awareness, and barriers to mental health services.
Standardized screening tools such as the Edinburgh Postnatal Depression Scale and Patient Health Questionnaire-9 provide healthcare professionals with practical methods for identifying patients who may need additional assessment. However, screening should always be followed by clinical evaluation, safety assessment, treatment planning, and appropriate follow-up.
The policy’s emphasis on interdisciplinary collaboration, electronic health record integration, patient education, and community resources demonstrates how healthcare organizations can create a more comprehensive approach to maternal mental health. Nurses and advanced practice nurses are particularly important because they frequently interact with patients and can establish the trusting relationships necessary for meaningful mental health assessment.
Ultimately, effective postpartum depression care requires more than completing a questionnaire. It requires a coordinated system in which screening leads to assessment, assessment leads to appropriate intervention, and patients continue to receive support throughout the perinatal period.
Postpartum depression is a clinically significant depressive condition associated with pregnancy or childbirth. It can involve persistent sadness, loss of interest, anxiety, guilt, fatigue, difficulty concentrating, problems with bonding, and thoughts of self-harm. Symptoms that interfere with daily functioning require professional evaluation.
Postpartum depression is relatively common. Estimates vary by population and diagnostic criteria, but approximately 10%–20% of postpartum individuals may experience clinically significant depressive symptoms.
Perinatal depression can begin during pregnancy or after childbirth. Symptoms do not necessarily appear immediately after delivery and can develop later during the postpartum period.
The Edinburgh Postnatal Depression Scale (EPDS) and Patient Health Questionnaire-9 (PHQ-9) are commonly used screening instruments. Other tools may also be used depending on the healthcare setting and clinical purpose.
No. An elevated EPDS score indicates that additional clinical assessment may be needed. A screening tool does not independently establish a psychiatric diagnosis.
Screening creates an opportunity to identify symptoms earlier, evaluate safety risks, initiate treatment, and connect patients with mental health and community resources.
Depending on the healthcare setting and applicable scope of practice, screening may involve obstetric providers, nurses, APRNs, primary care providers, pediatric clinicians, and mental health professionals.
Pediatric providers frequently interact with mothers during infant wellness visits. These encounters create additional opportunities to identify depression, particularly when symptoms develop after the mother’s routine postpartum care.
Yes. Untreated maternal depression can affect parent–infant bonding and may be associated with adverse developmental, behavioral, and emotional outcomes. Early identification and treatment can help support healthier family functioning.
Treatment depends on symptom severity, patient preferences, clinical history, and safety considerations. Options may include psychotherapy, antidepressant medication when clinically appropriate, social and peer support, community-based services, and urgent psychiatric intervention for severe symptoms.
A positive screening result should lead to further clinical assessment. The healthcare professional should evaluate symptom severity, functional impairment, psychiatric history, social support, and safety concerns before determining an appropriate treatment and follow-up plan.
American Academy of Pediatrics. (2019). Incorporating recognition and management of perinatal depression into pediatric practice. Pediatrics, 143(1), e20183259. https://doi.org/10.1542/peds.2018-3259
American College of Obstetricians and Gynecologists. (2023). Screening and diagnosis of mental health conditions during pregnancy and postpartum. ACOG Clinical Practice Guideline No. 4. https://www.acog.org/clinical/clinical-guidance/clinical-practice-guideline/articles/2023/06/screening-and-diagnosis-of-mental-health-conditions-during-pregnancy-and-postpartum
American College of Obstetricians and Gynecologists. (2023). Treatment and management of mental health conditions during pregnancy and postpartum. ACOG Clinical Practice Guideline No. 5. https://www.acog.org/clinical/clinical-guidance/clinical-practice-guideline/articles/2023/06/treatment-and-management-of-mental-health-conditions-during-pregnancy-and-postpartum
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. The British Journal of Psychiatry, 150(6), 782–786. https://doi.org/10.1192/bjp.150.6.782
CradleME. (n.d.). CradleME: Connecting Maine families with support services. https://cradleme.org/
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
National Institute of Mental Health. (n.d.). Perinatal depression. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/publications/perinatal-depression
Park, M., Brain, U., Grunau, R. E., Diamond, A., & Oberlander, T. F. (2018). Maternal depression trajectories from pregnancy to 3 years postpartum are associated with children’s behavior and executive functions at 3 and 6 years. Archives of Women’s Mental Health, 21(3), 353–363. https://doi.org/10.1007/s00737-017-0803-0
Postpartum Support International. (n.d.). Postpartum Support International. https://www.postpartum.net/
U.S. Preventive Services Task Force. (2016). Interventions to prevent perinatal depression: U.S. Preventive Services Task Force recommendation statement. JAMA, 316(6), 580–586. https://doi.org/10.1001/jama.2016.11886
Van der Zee-van den Berg, A. I., Boere-Boonekamp, M. M., Groothuis-Oudshoorn, C. G. M., Ijzerman, M. J., Haasnoot-Smallegange, R. M. E., & Reijneveld, S. A. (2017). Post-Up Study: Postpartum depression screening in well-child care and maternal outcomes. Pediatrics, 140(4), e20170110. https://doi.org/10.1542/peds.2017-0110
